Chris Belder (@chris_belder) 's Twitter Profile
Chris Belder

@chris_belder

ID: 1616018110955376641

calendar_today19-01-2023 10:22:10

3 Tweet

10 Followers

103 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

๐Ÿ”ฅThe 9th Round of Easy Loan, Earn $40 Reward is in progressโ—๏ธ โฐ Promotion Period: January 15th - Feburary 15th, 2025 ๐Ÿ‘‰ Register now and check more details at gate.io/campaigns/358

๐Ÿ”ฅThe 9th Round of Easy Loan, Earn $40 Reward is in progressโ—๏ธ โฐ Promotion Period: January 15th - Feburary 15th, 2025 ๐Ÿ‘‰ Register now and check more details at gate.io/campaigns/358
Jonathan Schott (@jmschott) 's Twitter Profile Photo
Jonathan Schott
@jmschott

2 years ago

What do we need to do to prepare health systems (and NHS England in particular) for emerging new therapies for Alzheimerโ€™s? Timed to coincide with #AAIC2023 โ€” my view with Chris Belder and Nick Fox now out in The Lancet Neurology thelancet.com/journals/laneuโ€ฆ Alzheimer's Research UK UCL News

Antoinette O Connor (@antoinetteocon) 's Twitter Profile Photo
Antoinette O Connor
@antoinetteocon

10 months ago

Very proud of this work discussing how to approach genetic testing in dementia. Thanks to all wonderful contributors! Practical Neurology

Jonathan Schott (@jmschott) 's Twitter Profile Photo
Jonathan Schott
@jmschott

10 months ago

Out today in The Lancet Neurology โ€” we review excess brain volume loss following amyloid immunotherapy and conclude that it is *not* related to neuronal loss. Download here: authors.elsevier.com/c/1jnzE5FFzL0Eโ€ฆ #ARPA Chris Belder The Lancet Neurology

Out today in <a href="/TheLancetNeuro/">The Lancet Neurology</a> โ€” we review excess brain volume loss following amyloid immunotherapy and conclude that it is *not* related to neuronal loss. Download here: authors.elsevier.com/c/1jnzE5FFzL0Eโ€ฆ #ARPA <a href="/chris_belder/">Chris Belder</a> <a href="/TheLancetNeuro/">The Lancet Neurology</a>